Home > PJ > News / Daily News

Return to PJ Online Home Page
The Pharmaceutical Journal Vol 266 No 7154 p870-872
June 30, 2001

News summary


Single-use syringes may promote sharing by drug misusers

Switching to single-use hypodermic syringes, or difficult-to-reuse (DTR) syringes, intended to reduce syringe and needle sharing among drug addicts is counter-productive and may actually lead to greater problems, according to campaigning groups. In effect, the transmission of hepatitis C and HIV would increase, contrary to the intention.

A recent meeting of the National Needle Exchange Forum (NNEF) heard that Lambeth, Southwark and Lewisham Health Authority had switched to the new syringes in May, but that their introduction to the drug abuse service was a disaster. Within days of their introduction a number of problems were identified by users of the service including poor quality needles, bendy plungers and difficulties drawing up. The result was that clients refused to take the new syringes, preferring to go without until supplies of familiar insulin syringes were arranged.

The NNEF, the UK Harm Reduction Alliance and Action on Hepatitis C have all advised needle exchanges not to introduce non-reuseable or DTR syringes and to liaise with their syringe suppliers in order to prevent health authorities switching their block purchasing contracts to these syringes without making special provision for needle exchanges.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal